+ Site Statistics
References:
52,572,879
Abstracts:
28,705,754
PMIDs:
27,750,366
DOIs:
25,464,004
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of nocturnal feeding on growth rate nitrogen 15 labeled glycine turnover and total body protein synthesis in type iii glycogen storage disease



Effects of nocturnal feeding on growth rate nitrogen 15 labeled glycine turnover and total body protein synthesis in type iii glycogen storage disease



Pediatric Research 16(4 Part 2): 262A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 028218529

Download citation: RISBibTeXText


Related references

Type i glycogen storage disease effects of glucose infusions on nitrogen 15 labeled glycine kinetics and total body protein synthesis. Pediatric Researchpart 2: 267a, 1982

Effects of a nocturnal nasogastric ng infusion inf of carbohydrate cho infused at an increased rate in children with glycogen storage disease type i gsd i on growth. Pediatric Research 23(4 Part 2): 396A, 1988

Effects of a nocturnal nasogastric infusion of carbohydrate infused at an increased rate in children with glycogen storage disease type i on growth. Clinical Research 35(6): 907A, 1987

Whole body protein turnover studied with nitrogen 15 labeled glycine and muscle protein breakdown in mildly obese subjects during a protein sparing diet and a brief total fast. Metabolism Clinical & Experimental 29(6): 575-581, 1980

A model for determination of total body protein synthesis based upon compartmental analysis of the plasma nitrogen 15 labeled glycine decay curve. Metabolism Clinical & Experimental 32(7): 646-653, 1983

Whole body protein turnover further studies with nitrogen 15 labeled glycine in obese women. American Journal of Clinical Nutrition 33(4): 945, 1980

Continuous nocturnal intragastric feeding in type I and type III glycogen storage disease. Pediatrie 41(3): 193-203, 1986

Comparison of nitrogen 15 labeled glycine aspartate valine and leucine for measurement of whole body protein turnover. Clinical Science 57(3): 281-284, 1979

Glycogen storage disease type I: effect of continuous nocturnal nasogastric feeding. Monographs in Human Genetics 9: 29-36, 1978

Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease. New England Journal of Medicine 294(8): 423-425, 1976

Type I glycogen storage disease: five years of management with nocturnal intragastric feeding. Journal of Pediatrics 96(3 Pt 2): 590-595, 1980

Glycogen storage disease type I. Results of treatment with frequent daytime feeding, combined with nocturnal intragastric feeding and with administration of an alpha-glucosidase inhibitor. European Journal of Pediatrics 140(2): 102-104, 1983

Resolution of the need for continuous nocturnal feeding in a patient with severe type I glycogen storage disease. Journal of Pediatrics 99(4): 602-605, 1981

Circulating lipids and lipoproteins in glycogen storage disease type I with nocturnal intragastric feeding. Journal of Lipid Research 29(2): 215-226, 1988

Type i glycogen storage disease 5 years of management with nocturnal intra gastric feeding. Journal of Pediatrics 96(3 Part 2): 590-595, 1980